Sorry, Your Requested Page Was Not Found.
Greetings! We apologize for the inconvenience, but the page, Scientific News Boston Scientific’s Stock Heads For Record High As Earnings Shine And Company Offers Upbeat Guidance is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3 - 18 months after the created date. We prefer to keep content fresh and current and not keep old news. Thanks for visiting today.Search RobinsPost News & Noticias
Boston Scientific’s stock heads for record high as earnings shine and company offers upbeat guidance
Boston Scientific Corp.’s stock rose 7% Wednesday to put it on track for a fresh record high after the medical-tech company beat analyst estimates for first-quarter earnings and offered upbeat ... Read More
Boston Scientific succeeds in pivotal trial for leadless pacemaker
Boston Scientific (BSX) says its pivotal trial for its modular cardiac rhythm management system, which includes a leadless pacemaker, met key goals. Read more here. Read More
Boston Scientific Corp BSX
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Read More
Boston Scientific's Upside With Cardiology Devices Drives Momentum
Mizuho Securities raises target for Boston Scientific, predicting double-digit growth in cardiology. Surge in Farapulse adoption and Watchman FLX upside driving momentum. Read More
Boston Scientific hits 52-week high on Q1 beat
Boston Scientific (NYSE:BSX) shares reached a 52-week high on Wednesday after the medical device maker topped Street forecasts with its Q1 2024 financials and raised its full-year outlook to a ... Read More
Decoding 18 Analyst Evaluations For Boston Scientific
Insights from analysts' 12-month price targets are revealed, presenting an average target of $81.22, a high estimate of $90.00, and a low estimate of $72.00. Marking an increase of 11.52%, the current ... Read More
Boston Scientific Lifts 2024 Profit Forecast On Strong Growth From Cardiovascular Devices, Stock Soars
Boston Scientific says businesses and pipelines, including the initial U.S. launch of the FARAPULSE PFA System, fueled Q1 results. Cardiology sales (16.5% growth) led the way for Cardiovascular ... Read More
Boston Scientific's stock heads for record high as earnings shine and company offers upbeat guidance
Medical-tech company said a new therapy for cardiac arrhythmias launched mid-quarter helped drive sales growth Boston Scientific Corp.'s stock rose 7% Wednesday to put it on track for a fresh ... Read More
Boston Scientific: Q1 Earnings Snapshot
MARLBOROUGH, Mass. (AP) — MARLBOROUGH, Mass. (AP) — Boston Scientific Corp. (BSX) on Wednesday reported first-quarter profit of $495 million. On a per-share basis, the Marlborough ... Read More
Blow Us A Whistle
Comments (Whistles) Designed By Disqus